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Thiopeptide antibiotics exhibit a profound level of
chemical diversity that is installed through cascades
of posttranslational modifications on ribosomal
peptides. Here, we present a technique to rapidly
explore the chemical space of the thiopeptide
GE37468 through codon randomization, yielding
insights into thiopeptide maturation as well as struc-
ture and activity relationships. In this incarnation of
the methodology, we randomized seven residues of
the prepeptide-coding region, enabling the genera-
tion of 133 potential thiopeptide variants. Variant
libraries were subsequently queried in two ways.
First, high-throughput MALDI-TOF mass spectrom-
etry was applied to colony-level expressions to
sample mutants that permitted full maturation of
the antibiotic. Second, the activity of producing
mutants was detected in an antibiotic overlay assay.
In total, 29 of the 133 variants produced mature
compound, 12 of which retained antibiotic activity
and 1 that had improved activity.
INTRODUCTION
The thiopeptides are a chemically diverse group of natural prod-
ucts known for their potent inhibition of protein synthesis in
Gram-positive bacteria and are potential therapeutic agents
against dangerous drug-resistant pathogens such as methi-
cillin-resistant Staphylococcus aureus (MRSA) (Walsh et al.,
2010, 2012). Thiopeptides are derived from a cascade of post-
translational modifications (PTMs) that transforms ribosomally
generated linear peptides into highly elaborated macrocyclic
architectures rich in thiazole, oxazole, and dehydro amino acids
(Arndt et al., 2009; Bagley et al., 2005). As opposed to nonribo-
somal peptide synthesis (NRPS)—responsible for installing the
peptide bonds in many small molecule peptide-based natural
products such as penicillins, vancomycin, daptomycin, and
cyclosporin—this form of postribosomal peptide synthesis
(PRPS) has the virtue that DNA sequence is directly coupled to
the peptide structure that scaffolds the mature antibiotic (McIn-1600 Chemistry & Biology 19, 1600–1610, December 21, 2012 ª2012tosh et al., 2009; Nolan andWalsh, 2009). This biosynthetic logic
facilitates the use of gene mutagenesis to evaluate the chemical
space that is tolerated by the dedicated PTM enzymes to convert
nascent peptides into complex molecular structures with poten-
tially improved antibiotic properties (Field et al., 2010).
Thiopeptide antibiotics represent promising targets for this
type of synthetic biology because their highly constrained
macrocyclic architectures are the most heavily modified class
of PRPS natural products. They are generated from small, 50–
60 residue, ribosomal prepeptides that undergo more than
a dozen PTMs in the C-terminal 14–16 residues to achieve an
extraordinary level of chemical diversity starting from only the
20 proteinogenic amino acids (Walsh et al., 2010, 2012). These
transformations represent a convergence of biosynthetic logic
from the (1) lantibiotics to create dehydroalanine (dhA) and dehy-
drobutyrine (dhB) residues from the dehydration of serine (Ser)
and Thr, respectively (Chatterjee et al., 2005), and (2) cyanobac-
tins, plantazolicin, and microcin B17 pathways to create thia-
zoles, oxazoles, and methyloxazoles from the cyclodehydration
of Cys, Ser, and Thr, respectively (Melby et al., 2011). The signa-
ture element of thiopeptides is the central nitrogenous hetero-
cycle, typically presented as a 2,3,6-trithiazolyl pyridine (illus-
trated for GE37468 in Figure 1). The pyridine is formed at a late
step from cycloaddition of two Ser-derived dhA residues at the
same time macrocyclization is effected (Bowers et al., 2010b);
the spacing of these Ser residues determines the number of
atoms in the macrocycle. Net cycloaddition between Ser1 and
Ser10 (numbering of the core peptide) gives the 26-membered
(atoms) macrocycle found in the thiocillin, thiostrepton, and no-
siheptide subclass, whereas coupling between Ser1 and Ser11
yields the 29-membered macrocycle in GE2270, GE37468, and
thiomuracin (Morris et al., 2009) (Figure S1 available online).
The 26-membered trithiazolylpyridine scaffolds target the 50S
ribosome between the L11 protein and adjacent 23S rRNA
helices to inhibit protein translation (Baumann et al., 2010). In
a distinct mode of action, the 29-membered macrocyclic antibi-
otics target the conditional GTPase, EF-Tu, and block its ability
to chaperone aminoacylated tRNAs to the ribosome (Parmeg-
giani et al., 2006). Although total syntheses of a small number
of both 26- and 29-membered thiopeptides have been achieved
(Mu¨ller et al., 2007; Nicolaou et al., 2005) because of the struc-
tural complexity of both architectures, these molecules are not
readily susceptible to structure activity relationship (SAR) deter-
mination via chemical approaches. Thus, in vivo mutationalElsevier Ltd All rights reserved
Figure 1. GE37468 Biosynthesis and
Residue Randomization
(A) Codon randomization created libraries of
variant GetA prepeptides that were subject to
a cascade of in vivo PTM provided by enzymes
encoded in the GE37468 cluster (top). Randomi-
zation at residue 5 (represented by X) is shown as
an example.
(B) In total, codon randomization was conducted
at seven residues (illustrated by Xs). Variants were
screened by MALDI-TOF mass spectroscopy to
assay for PTMmaturation (left) and by overlay with
B. subtilis for activity (right).
See Figure S1 for structures of related thiopep-
tides, thiomuracin, and GE2270.
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analogs thatmay improve our understanding of howmacrocyclic
ring size and chemical functionality dictate targeting.
In previous efforts, we have used synthetic genes to carry out
alanine (Ala) and Ser scans of the 14 C-terminal core residues of
the thiocillin prepeptide gene that ultimately get morphed into
the mature thiocillin antibiotic (Acker et al., 2009; Bowers et al.,
2010a, 2010b, 2012; Young andWalsh, 2011). Similar prepeptide
gene replacement efforts have been applied to produce thio-
strepton antibiotic variants following identification of the tsr
biosynthetic gene cluster (Li et al., 2012). These strategies
generate mutants one at a timewith bias in the design of the vari-
ants. In this study, we designed an approach that allows codon
randomization in the 15 C-terminal prepeptide core residues of
GE37468 inorder to correlatemutantswithbothPTMmaturations
and SAR in the 29-membered macrocycle subclass of
thiopeptides (Figure 1).GE37468harborsadiversearrayof chem-
ical functionalities and is remarkably potent against Gram-posi-
tive bacteria (minimal inhibitory concentration [MIC] of 0.016–
0.03 mg/ml against MRSA; Stella et al., 1995, 1997). Our recentChemistry & Biology 19, 1600–1610, December 21, 2012 ªdemonstration of facile heterologous
production makes it ideally suited for
diversification studies (Young and Walsh,
2011). In addition, as a representative of
the 29-membered subclass, GE37468
targetsEF-Tu (Ferrari et al., 1995;Marinelli
et al., 1996), complementingpreviousmu-
tasynthetic studies of the 50S ribosome-
targeting thiocillins and thiostrepton.
Finally, there is significant pharmaceutical
interest in developing the 29-membered
class of thiopeptides exemplified by the
recent advancement of a GE2270 analog
to clinical trial for treatment ofClostridium
difficile colitis (LaMarche et al., 2012a).
RESULTS
Improved GE37468 Expression
with Engineered Streptomyces
‘‘Superhosts’’
Previously, we reported the heterologous
expression of the biosynthetic genecluster for GE37468 from Streptomyces strain ATCC 55365 in
S. lividans and construction of a small number of analogs via pre-
peptide gene mutagenesis (Young and Walsh, 2011). Although
expression in S. lividans was sufficient to produce variants
focused on understanding the transformation of Ile8 to the
unique b-methyl-d-hydoxy-leucine (mhP) residue, the proposed
screening of prepeptide codon randomization libraries necessi-
tated a more robust expression system. To achieve this, we
compared GE37468 expression in the original heterologous
host S. lividans with other model hosts, S. coelicolor and
S. albus, as well as three engineered Streptomyces strains (Fig-
ure 2). S. coelicolorM145 gave yields comparable to S. lividans,
whereas S. albus gave approximately half the yields of fully
matured GE37468 under our expression conditions. Increased
expression was achieved through the use of Streptomyces
derivatives referred to as ‘‘superhosts’’ for their engineered
ability to increase the biosynthesis of heterologously incorpo-
rated clusters through the deletion of endogenous natural
product gene clusters (Baltz, 2010). In this vein, engineered
S. avermitilis strain SUKA17 gave yields of GE37468 that were2012 Elsevier Ltd All rights reserved 1601
Figure 2. GE37468 Yields
Liquid chromatography traces (UV350) of mycelia methanolic extracts from
expressions using the pSETGE1 vector described in Young and Walsh (2011).
Streptomyces ATCC 55365 is shown at the top (WT, black). Red chromato-
grams (middle) represent GE37468 heterologous expression hosts: S. lividans
TK24, S. albus, S. coelicolor M145, and engineered strains S. avermitilis
SUKA17, S. coelicolorM1146, and S. coelicolorM1152. Blue chromatograms
(bottom) show ectopic complementation of the getA knockout cassette
pSETGE-getATFRT, with the getA gene on the pKC1218 or pMS82 plasmid.
Yields from pKC1218 were only detectable by HR-LCMS (see Figure S2A).
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increase in yield was achieved with the engineered
S. coelicolorM145 derivative, M1146, which lacks four endoge-
nous natural product biosynthetic clusters and gave a 19-fold
increase over our initial system (Gomez-Escribano and Bibb,
2011). Yields were maximized to 30-fold better than the original
S. lividans system with S. coelicolor strain M1152—a M1146
derivative that harbors a C1298T point mutation in rpoB (RNA
polymerase b subunit) previously reported to increase heterolo-
gous expression pleiotropically (Gomez-Escribano and Bibb,
2011). Expression of GE37468 and analogs in this work was
thus performed in this engineered strain.1602 Chemistry & Biology 19, 1600–1610, December 21, 2012 ª2012Complementation of the getA Prepeptide Gene on
a Mutagenizable Plasmid
To optimize construction and assay of GE37468 mutants in
M1152, a two-plasmid complementation system was tested.
The previously reported pSET-getA::FRT plasmid is a nonex-
pressing variant of the GE37468 gene cluster cassette
(pSETGE1) in which the getA prepeptide gene was knocked
out leaving a flippase recognition target (FRT) scar, whereas all
other get genes required for PTM remained in frame (Young
and Walsh, 2011). With this plasmid incorporated into M1152
as a host, we tested ectopic expression of getA from the strong
ermE promoter (derived from the erythromycin gene cluster;
Bibb et al., 1985) in the autonomously replicating pKC1218
plasmid (Bierman et al., 1992). Complementation in this fashion
gave low yields of GE37468 (Figures 2 and S2A), indicating
that additional elements surrounding the getA gene may be
necessary for regulation/expression of the prepeptide. There-
fore, the getA gene along with 350 bp of upstream DNA and
150 bp downstream DNA was placed in the promoterless
pMS82 E. coli-Streptomyces shuttle vector (Gregory et al.,
2003) (Figure S2B). Ectopic expression from this construct
gave 80% the yield of GE37468 as was found from the single-
plasmid cassette pSETGE1, thus constituting a useful small
plasmid for mutagenesis in E. coli and subsequent conjugative
transfer to M1152.
Evaluation of Tolerance for Mosaic Prepeptide Genes
in the GE37468 Maturation Pathway
Understanding the specificity of enzymes within thiopeptide
gene clusters to act on exogenous, naturally occurring, prepep-
tide genes is of interest as an early step in testing the viability of
assembling combinatorial biosynthetic systems. Thus, pMS82
complementation was employed to assess the potential for
the PTM enzymes of the GE37468 biosynthetic cluster to
process prepeptide-coding sequences for thiomuracin or
GE2270 (Morris et al., 2009). Although the full-length prepepti-
des for thiomuracin and GE2270 are similar to GE37468 (67%
and 54% identity with GetA, respectively; Figure S1), we
focused on the coding region that scaffolds the mature antibi-
otic. This sequence for thiomuracin differs from GE37468 by
only the T2C mutation. Incorporation of this mutation into the
getA prepeptide created a mosaic gene consisting of the
GE37468 leader peptide and thiomuracin-coding region.
Expression of this construct gave robust yields providing an
example of a thiopeptide gene cluster acting on the coding
sequence for a naturally occurring relative (see below for further
discussion and characterization of this mutant). The coding
region for the GE2270 prepeptide contains the T2C mutation
and three additional mutations: F5V, Y7G, and I8F. Expression
of this mosaic construct containing all four mutations in the
getA-coding region was not tolerated and produced no
matured product. Because intermediates were not detected,
it is unknown which step(s) in maturation of the variant core
prepeptide was affected. This indicated that amino acid
changes significantly altered the maturation of the prepeptide.
Therefore, to assess impact of residue changes on peptide
maturation as they relate to PTM substrate tolerances, we
devised the codon randomization and screening methodology
described below.Elsevier Ltd All rights reserved
Figure 3. MALDI-TOF Heatmap
MALDI-TOF mass spectrometry performed on individual library colonies
produced a four-mass fingerprint for expressing variants (top). Spectra were
converted into a ‘‘heatmap’’ (bottom) by correlating peak intensity with color.
For clarity, 12 randomly chosen samples are shown to illustrate permissibility
for mutation at each residue (X, any amino acid). The full data set of 476
samples is presented in Figure S3B. Themass at approximately 1,325 Da in the
heatmap is an unrelated S. coelicolor metabolite.
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for Cyclic Scaffolds by MALDI-TOF Mass Spectrometry
To interrogate the GE37468 PTM pathway for permissible muta-
tions, we turned to codon randomization (saturation mutagen-
esis). To assess the viability of this method, six residues within
the GE37468 macrocycle and one residue outside of the macro-
cycle were chosen for randomization, one codon at a time. In an
effort to sample mutation at each possible type of PTM in
GE37468, two azole-generating residues (Thr2 and Cys4), three
unmodified residues (Asn3, Phe5, and Tyr7), one dehydrated
residue (Ser13), and one oxygenated residue (Ile8) were chosen.
Ser1 and Ser11, which contribute to the central pyridine ring,
were not modified in order to maintain a stable scaffold for
construction of the pyridine core in the mature antibiotic.
Libraries were created using NNK degenerate primers (N = any
nucleotide, K = G,T) for getA oligonucleotide-directed randomi-
zation (Nov, 2012; Zheng et al., 2004). Mutation in this way incor-
porates at least 1 codon for each amino acid using 32 total
codons, while eliminating nonsense mutations from 2 of the
stop codons (TGA and TAA). This allows encodement of all 20
amino acid mutants at each of the seven sites for a total of 133
getA variants (not including seven wild-type sequences). To
confirm diversity, 10 clones from each library (70 total clones)
were sequenced. Of the 20 amino acids, 17 were represented
in this sample size, in good agreement with the expected frac-
tional completeness of the library approximated by the Poisson
distribution (Figure S3A) (Patrick et al., 2003).
To sample the production of mature GE37468 variants from
the genetic libraries, liquid culture and extraction—which can
be laborious when screening large numbers of mutants—were
circumvented by initial evaluation of expression from colonies
on solid media (vide infra). Codon-randomized getA libraries in
M1152 were grown on agar plates at a density to produce indi-
vidual colonies. A total of 68 colonies were randomly chosen
from each library (expected to cover approximately 90% of
the diversity; see Figure S3A) and picked to a microtiter plate
containing methanol. The colonies in methanol were directly
mixed with MALDI-TOF matrix, without prior removal of the
cell debris, and the entire mixture was spotted onto a 384-well
MALDI-TOF plate for high-throughput analysis. Wild-type
GE37468 produces a distinct pattern of ionization under these
conditions (Figure 3, top); this four-mass fingerprint could be
used to identify producing mutants. To rapidly scan for these
masses, a heatmap was created by stacking acquired spectra
in the vertical axis and correlating peak height with color inten-
sity (Figures 3 and S3B) (Esquenazi et al., 2011). Examination of
this plot for unique mass sets in the 1,200–1,400 m/z mass
range showed that mutation is permissible at six of the seven
residues, with Cys4 as the exception. Residues Phe5, Tyr7,
and Ile8 had the most tolerance for mutation, whereas residues
Thr2, Asn3, and Ser13 accepted fewer mutations (summarized
in Figure 4). Spectra lacking masses in this range indicated
that the getA gene variants were either incapable of production
or produced macrocyclic compound below the detection limit of
this method (expression could be detected at least 250-fold
lower than wild-type production, or 0.25 mg/l; Figure S3C).
Detailed inspection of all spectra revealed 29 unique mass
spectra (not including wild-type masses) in the library sampling,
corresponding to 22% of the 133 possible variants that could beChemistry & Biology 19, 1600–161fully processed to the mature macrocycle at reasonable yields
(Figure S4A).
A portion of the parent colony (that had not been subjected to
extraction) that corresponded to these unique spectra was
cultured in liquid media and investigated by sequencing of the
getA gene and by high-resolution liquid chromatography mass
spectrometry (HR-LCMS) analysis of culture extracts. Collec-
tively, this analysis identified 153matured compounds (including
partially or alternatively processed intermediates; see Fig-
ure S3C) resulting from the 29 unique prepeptide scaffolds,
which allowed insights into PTM timing and specificity.
Substitution at residue Thr2 (processed to the methyloxazole
in mature GE37468) was only tolerated by substitution with Cys
and Ser. Both of these residue substitutions were fully pro-
cessed to a thiazole or oxazole, respectively (Figure 4). This
may reflect a necessity for a heterocycle at this locus to set
up late-stage pyridine ring-forming macrocyclization. Mutation
of Asn3 to Ser or Cys was also permissible. At residue 3, the
major fraction of the resultant GE37468 variants lacked PTM;
however, small amounts (less than 5% of the major product)
of dehydrated (dhA) or cyclodehydrated Ser3 (oxazoline) (indis-
tinguishable by mass) could be detected by HR-LCMS as well
as small amounts of full conversion to the oxazole for N3S
(less than 1%; Figures S3C and S3H). Although formally the
alternate processing of other heterocycles in the peptide cannot
be ruled out, the lack of corresponding masses for other
mutants discussed below provides evidence that the GetI0, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1603
Figure 4. GE37468 Mutants and Impacts on PTM Processing
The 12 active variants identified in the overlay assay are listed in green. Inactive mutants found in MALDI-TOF assay, but not in the overlay assay, are listed in
black. An asterisk indicates that downstream processing is affected in the dominant product. No mutants were tolerated at residue 4. See also Figures S3B–
S3GG and S4A.
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residues 2, 4, 6, 9, 10, and 12 may not be fully regiospecific and
may act, albeit inefficiently, for cyclization and aromatization in
the N3S mutant.
Residues Phe5 and Tyr7 accepted a wider range of mutations
in the library sampling. Nonaromatic residues at either of these
positions prevented the double-oxygenative processing of Ile8
to mph8 by the monooxygenase GetJ (Figure 4). Additionally,
the dominant product for molecules with a nonaromatic substitu-
tion at residues 5 or 7 and an unmodified Ile at residue 8was a di-
hydro variant (+2 Da by mass spectrometry), which was
produced at two to five times the yields of the dehydrogenated
product (Figure S3C). This dihydro compound is likely the result
of incomplete dehydrogenation at one of the three thiazoles or
methyloxazole and was previously detected as the dominant
product of the mhP8Ile variant produced by GetJ knockout
(Young and Walsh, 2011). Mutation of Ile8 to small residues
was well tolerated, which except for Leu, were not substrates
for the monooxygenase GetJ. Oxygenation of Leu8 occurred
to the d alcohol (d-OHLeu) as the major product and complete
transformation to the hemiaminal g-methyl-d-hydroxyproline1604 Chemistry & Biology 19, 1600–1610, December 21, 2012 ª2012(g-mhP) produced at 15% the yield of the major alcohol product
as determined by HR-LCMS.
Identification of Linear Precursors from S13X Variants
Substitution at Ser13 gave only Ala13 or Gly13 cyclic variants;
however, additional compounds were identified by HR-LCMS
of culture extracts that corresponded to uncyclized (linear) pre-
peptides. These compounds were identified based on their
absorption at 254 nm, but not at 350 nm, indicating the pres-
ence of thiazoles but lack of extended conjugation through a tri-
thiazolylpyridine core as previously reported by Bowers et al.
(2010b). To confirm that these compounds were linear precur-
sors, two additional variants, S13N and S13L, for which the
signature mass fingerprint for cyclic compounds shown in Fig-
ure 3 was not found by MALDI-TOF, were expressed in liquid
shake flasks, extracted, and analyzed by HR-LCMS. The major
product of both S13N and S13L corresponded to linear prod-
ucts, which were confirmed by mass spectrometry fragmenta-
tion (MS/MS) (Figures S4B–S4G). In each variant, the linear
precursor was found to lack dehydration at Ser11, indicating
that the mutation of Ser13, especially to larger amino acids,Elsevier Ltd All rights reserved
Figure 5. Bacillus Antibiotic Overlay Assay
(A) Colonies of S. coelicolorM1152 or S. coelicolor
M1152 + pSETGE1 were grown on BTT agar
plates followed by overnight incubation with the
designated Bacillus strain. B. subtilis PY79 has no
engineered resistance, strain G1674 is resistant to
29-membered thiopeptides, and strain BSZ-9 is
resistant to 26-membered thiopeptides. B. cereus
ATCC 15479 is resistant to 26-membered thio-
peptides. The B. subtilis BSZ-9 zone of inhibition
exhibits small colonies of S. coelicolor due to the
exceptionally slow growth rate of BSZ-9.
(B) Randomization and screening at residue Phe5
(red X indicates any amino acid) are illustrated as
an example. The core region of the GetA prepep-
tide is shown (top) with degenerate oligonucleo-
tide sequence used for codon randomization and
DNA frequency logo. Incorporation of this library
into S. coelicolor M1152 and overlay with
B. subtilis PY79 is shown at bottom.
See Figure S5 for details on compound purifica-
tion.
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absence of a dhA11 residue subsequently prohibited macro-
cyclization by GetF.
Coculture Overlay Assay with Codon-Randomized
Libraries
We next developed an assay to screen the codon-randomized
libraries for antibiotic activity in an unbiased, scalable format
using an antibiotic overlay method on agar plates. This method
exploited the robust expression profile from S. coelicolor
M1152. Additionally, the deletion of endogenous natural product
clusters in M1152 minimized host antibiotic production that
might interfere with assaying the activity of expressed
GE37468 analogs. B. subtilis PY79 was chosen as a model
Gram-positive organism for overlays based on its sensitivity to
GE37468, nonvirulence, and precedent for coculture with
S. coelicolor (Yang et al., 2009).
To test the utility of this method, colony expression from
M1152 expressing wild-type GE37468 from pSETGE1 was opti-
mized on BTT agar plates by overlay with B. subtilis PY79 in soft
agar. After overnight incubation, strain M1152 containing
pSETGE1 produced a clear zone of inhibition, whereas M1152
alone did not antagonize B. subtilis growth (Figure 5A). To
confirm that the phenotype was a result of EF-Tu inhibition, colo-
nies were overlaid with B. subtilis G1674, which harbors an
insensitive G275S (E. coli numbering) mutation in EF-Tu (Sosio
et al., 1996). As expected, growth of G1674 was unaffected.
To further confirm that the resistance mechanism was specific
to EF-Tu, overlay was tested with B. subtilis BSZ-9 or
B. cereus ATCC 15479, which exhibits resistance to 26-member
thiazolyl peptides through a knockout or mutant L11 protein,
respectively (Baumann et al., 2010; Zhang et al., 2001).
B. cereus ATCC 15479 is responsible for thiocillin production
and also encodes export pumps predicted to confer thiocillin
resistance. Neither BSZ-9 nor B. cereus ATCC 15479 exhibited
resistance to M1152 harboring pSETGE1, confirming that the
EF-Tu target of GE37468 is distinct from ribosomal resistance.Chemistry & Biology 19, 1600–161A total of 600 colonies from each codon randomization library
was grown on BTT plates for 6 days followed by overlay with
B. subtilis PY79. Screening this number of colonies corre-
sponded to an 18.75-fold degeneracy and gave a >99.99%
confidence that all 32 sequence variants (resulting from NNK
mutagenesis) were represented (Figure S3A). Colonies that
produced zones of inhibition (Figure 5B) were restreaked on
fresh plates, and the getA gene was sequenced to identify the
library variant (resultant variants colored green in Figure 4).
Those that did not produce zones of inhibition indicated mutants
that were incapable of production as noted above, were not
secreted, or gave products that lacked sufficient antibiotic
activity to produce a zone of inhibition (an MIC less than at least
0.5 mg/ml as determined by the weakest antibiotic MIC found in
the screen). Twelve of the 29, or 41%, of the permissible muta-
tions identified by MALDI-TOF were found to retain activity in
the overlay screen and were then purified from expressions in
liquid shake flasks for quantification of antibiotic activity against
B. subtilis PY79 and two strains of MRSA (Table 1).
Two of the six permissible mutants from the left half of the
molecule (residues 2, 3, and 4) retained activity. Mutant T2S
had equal activity to the wild-type compound (0.016 mg/ml),
whereas T2C had 2-fold improved activity (0.0078 mg/ml) indi-
cating that the methyloxazole, thiazole, and oxazole residues
have small, but significant, impacts on antibiotic activity. None
of the permissible mutations at Asn3, which is conserved in
GE2270, thiomuracin, and GE37468, retained antibiotic activity.
On the lower half of the molecule (residues 5 and 7), 2 of the 12
detected mutants from the MALDI-TOF sampling retained
activity. Mutant Y7F was 4- to 8-fold less active (0.063–
0.13 mg/ml depending on strain), whereas mutant F5Y was 8-
to 16-fold less active (0.13–0.25 mg/ml) than wild-type. To our
knowledge, it is unknown whether this marked decrease in anti-
biotic activity is the result of altered macrocyclic ring conforma-
tion or a direct modulation of themutant’s interaction with EF-Tu.
No mutation to nonaromatic residues retained activity, likely
because of the additional defects in processing (lack of0, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1605
Table 1. MIC of GE37468 Variants Produced in This Study
MIC (mg/ml)a
Variant PTM B. subtilisb MW2c COLd
GE37468 Wild-type 0.016 0.016 0.016
T2C Thiazole 0.0078 0.0078 0.0078
T2S Oxazole 0.016 0.016 0.016
F5Y 0.13 0.13 0.25
Y7F 0.063 0.063 0.13
I8P 0.063 0.031 0.063
I8L d-OHLeu 0.063 0.031 0.031
I8L g-mhP 0.031 0.016 0.031
I8S 0.25 0.13 0.13
I8T 0.063 0.031 0.063
I8V 0.25 0.063 0.13
I8A 0.063 0.031 0.063
S13A 0.25 0.25 0.25
S13G 0.5 0.5 0.5
See Figure S5 for compound isolation.
aMICs determined by overnight serial dilution culture.
bBacillus subtilis PY79.
cMRSA MW2.
dMRSA COL.
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mutations noted above.
Mutation at residue 8 was the most promiscuous with six
amino acids (Ala, Val, Pro, Leu, Ser, and Thr) able to replace
the native mhP8 residue with retention of on-target antibiotic
activity. These mutations were between 2- and 16-fold less
active (0.031–0.25 mg/ml) than wild-type GE37468. Residue
mhP8 was previously hypothesized to contribute to activity via
the structural constraint imparted on the macrocycle (Young
and Walsh, 2011). Notably, the swap to proline, mhP8Pro, is
a 2- to 4-fold (0.031–0.063 mg/ml) weaker antibiotic, whereas
replacement with the cyclic g-mhP8 residue (derived from
Leu8) is equal to 2-fold weaker (0.016–0.031 mg/ml) than wild-
type, indicating that themethyl and hydroxyl groups play a signif-
icant role in EF-Tu binding. Both the Ala and Gly mutations at
residue 13 retained activity, albeit markedly decreased. S13A
exhibited a 16-fold decrease in activity (0.25 mg/ml), whereas
S13G was 32-fold less active (0.5 mg/ml) than wild-type
GE37468.DISCUSSION
Methodology Considerations
Using saturation mutagenesis, we have tested the substrate
specificity of the GE37468 cluster to process variants of the
GetA prepeptide. This methodology has the benefit of being
unbiased in its design for exploration of chemical space. A
similar approach from researchers at Novacta Biosystems
used saturation mutagenesis to generate all possible single-
point mutation variants at individual residues of the lantibiotics
mersacidin and actagardine (Appleyard et al., 2009; Boakes
et al., 2012); however, the methodology was limited by the
necessity to construct 19 separate plasmids to achieve satura-1606 Chemistry & Biology 19, 1600–1610, December 21, 2012 ª2012tion at each residue. A codon randomization approach using
NNT mutagenesis was employed by A. James Link’s lab to
explore the biosynthetic tolerances of the ribosomally synthe-
sized lasso peptide microcin J25 (Pan and Link, 2011); however,
the NNT codon only encodes 15 of the 20 amino acids. To
encode all 20 amino acid variants at a single codon, Sonomoto
and coworkers used NNK mutagenesis to randomize residues
in the lantibiotic nukacin (Islam et al., 2009). The NNK codon
allows reduced degeneracy while encoding all 20 amino acids
in a single oligonucleotide-directed mutagenesis experiment
and as such was used for saturation mutagenesis in this work.
In codon randomization approaches, the confidence that all
encodable members of an NNK mutagenesis library are repre-
sented in a screen is proportional to the number of colonies
screened. By analyzing 68 colonies from each library in the
MALDI-TOF screen, we expected to sample approximately
90% of library diversity (17–18 of the 20 possible amino acids),
which was supported by the Poisson-like distribution of
randomly sequenced clones (Figure S3A). On the other hand,
600 colonies were screened in our overlay assay corresponding
to a >99.99% confidence that all library clones were represented
(Patrick et al., 2003). Library screening in both methods was
streamlined at the colony level to circumvent the laborious
process of separate fermentations, allowing us to cumulatively
sample hundreds of library members and ultimately focus on
12 active variants.
Execution of this strategy depended on sufficient peptide
expression to increase the probability of detecting weakly ex-
pressing analogs. This was accomplished by expression in the
modified S. coelicolor M1152 strain, which increased yields
more than 30-fold (to 69 mg/l; Figure 2) over the original heterol-
ogous producer and allowed detection of variants at 0.5% the
yield of wild-type GE37648 (Figure S3C). MALDI-TOF mass
spectrometry analysis from single-colony extracts allowed effi-
cient visualization of the production of novel scaffolds in the
absence of assayable antibiotic activity. Expression of variants
from M1152 was also critical to detect the activities of
GE37468 variants in overlay assays. This was aided by the
quadruple knockout of gene clusters that encode actinorhodin,
prodiginine, CPK (cryptic polyketide synthase), and CDA
(calcium-dependent antibiotic) in the S. coelicolorM1152 strain,
which limited endogenous antibiotics that could interfere with
assaying the activity. This screen was a preamble to larger
growth and isolation for MIC quantification of the 12 active vari-
ants. Thus, the combination of the two approaches provided
valuable insight into the SAR of maturation, production, and
activity of the thiopeptide variants.
Structural Considerations
Using these screening strategies, we were able to witness unan-
ticipated PTM patterns that occur from unbiased mutation. For
instance, nonaromatic residues at positions 5 or 7 prevented
Ile8 processing to mhp8, suggesting that the native aromatic
residues are necessary for substrate recognition by the GetJ
monooxygenase. This oxygenative transformation is set prior
to ring closure, evidenced by its presence in linear precursor
peptides found in the S13X mutants (Figures S4B–S4G). Inhibi-
tion of this PTM yielded an unmodified Ile at position 8 and led
to the production of a dihydro analog of the expected product.Elsevier Ltd All rights reserved
Figure 6. Major Contacts between 29-Membered Thiopeptides and EF-Tu
(A) Crystal structure of GE2270A (dark-blue sticks) complexed with T. thermophilus EF-Tu (green ribbon, E. coli numbering) and GDPNP (GTP analog, not visible)
adapted from PDB 2C77 (Parmeggiani et al., 2006). Residues forming important contacts are illustrated in light blue. Residues involved in resistance mutations
are noted in red: G275S occurs in B. subtilis G1674 used in this work.
(B) EF-Tu contacts (black, E. coli numbering) identified fromGE2270A-EF-Tu structures complexedwith GDP orGTP andmapped ontoGE37468 (blue). GE37468
residues in bold were subject to randomization. Contacts and references are tabulated in Table S1. Contact with residue Q98 from T. thermophilus EF-Tu is only
formed in the GTP bound state.
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recognition by the GetG/GetK dehydrogenases for thiazole/
methyloxazole aromatization; however, further investigation is
warranted to determine which thiazole or methyloxazole lacks
dehydrogenation.
The conservation of small amino acids at position 13 provided
a somewhat surprising result. Placed outside the macrocycle, it
may be expected that mutation of this residue would have little
impact on ring maturation. Here, we traced the inability of
S13X variants to macrocyclize to a lack of dehydration at the
cycloaddition-fated residue Ser11 through identification of linear
peptide precursors. In general, dehydration of Ser11 and subse-
quent macrocyclization decreased with increasing size of the
amino acid at residue 13 (S13G > S13A > S13N > S13L) (Fig-
ure S4B), suggesting a steric interaction with the GetD or GetE
dehydratase. The major linear product of the S13L variant con-
tained a Ser11 that had failed to undergo dehydration and
Ser14 that had been hydrolyzed off to yield a C-terminal acid
(rather than amide). N-terminal proteolytic trimming had released
residues upstream of the dhA1, which subsequently hydrolyzed
to themethylketone (Bowers et al., 2010b) (Figure S4C). All PTMs
besides dehydration of Ser11 were set in this molecule, indi-
cating that GE37468 macrocyclization is a late-stage modifica-
tion as found in the thiocillins. Unlike oxygenation of Val6 of thi-
ocillin (Bowers et al., 2010b), we found that double-oxygenative
processing of Ile8 had proceeded prior to ring closure (Figures
S4D and S4G). Although linear variants were not readily detect-
able in other mutants beyond S13X, these findings suggest that
detection of additional linear, partially processed intermediates
from other variants (i.e., from ring expansion or contraction
experiments [Bowers et al., 2012] as well as knockout mutants
[Bowers et al., 2010b]) will give insights into the timing of the
gauntlet of PTM events in the GE37468 pathway and other
related pyridine-containing thiopeptide antibiotics.Chemistry & Biology 19, 1600–161A major goal of synthetic biology in this context is a compre-
hensive understanding of the logic controlling thiopeptide
biosynthesis in order to engineer molecules with custom-tailored
chemistries (Benner and Sismour, 2005; Young et al., 2011).
Previously, we showed that oxygenative transformation of Ile8
to mhP8 is carried out by the GetJ monooxygenase through
a proposed regiospecific tandem double-hydroxylation/cycliza-
tion mechanism (Young and Walsh, 2011). TpdJ, an analog of
GetJ in the thiomuracin cluster, produces seven different
oxygenation states on thiomuracin’s Ile8 and has been shown
to modulate activity against different species of bacteria (Morris
et al., 2009). The ability to control this oxygenation may be
a useful synthetic biology technique to design more active vari-
ants. Here, we report substrate mutation as an alternate (and
complementary) approach to producing oxygenation variants
with GetJ. Mutation of Ile8 to Leu8 yielded two new oxygenated
residues, g-mhP and d-OHLeu, not yet found to occur naturally in
thiopeptides. This lays the groundwork for future research
focused on swapping oxygenases among clusters, which,
combined with prepeptide substrate mutation, has the potential
to yield an arsenal of oxidation patterns for in vivo synthetic
biology.
SAR Considerations
A total of 12 GE37468 variants resulting from the 29 permissible
mutations found in the MALDI-TOF sampling experiments re-
tained antibiotic activity, with 1 variant (T2C) eliciting slightly
improved activity, validating this methodology in the construc-
tion of novel antibiotics. The activity, or lack thereof, for variants
can be assessed by examining the reported crystal structure of
GE2270 complexed with EF-Tu and the GTP analog GDPNP
(Figure 6; Table S1) (Parmeggiani et al., 2006). Important
contacts between the GE2270 and EF-Tu are shown in Figure 6A
and those relevant to GE37468 charted in Figure 6B (Heffron and0, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1607
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Parmeggiani et al., 2006). GE2270 and GE37468 have very
similar antimicrobial profiles and are expected to engage in
similar binding mechanisms (Stella et al., 1995, 1997). Notably,
Asn3 forms two hydrogen bonds: one with the backbone amide
of F261 on EF-Tu, and one intramolecular transannular hydrogen
bond with the carbonyl of Tyr7. It is therefore not surprising that
this residue is conserved in GE2270 and thiomuracin and could
not be mutated in GE37468 with retention of activity. Another
hydrogen bond bifurcated between the b-hydroxylated Phe8 of
GE2270 and Asp216 and Thr228 of EF-Tu may explain why
oxygenation at residue 8 in thiomuracin, GE2270, and
GE37468 is conserved. Although not isosteric with the b-OHPhe
in GE2270, the hydroxyl group of mhP8 in GE37468 may also
hydrogen bond with these residues or the neighboring Glu215.
Interestingly, GE37468 variants with hydroxyl groups that are
isosteric with the b-OHPhe hydroxyl group (I8S and I8T) do not
retain full activity. The most potent Ile8 mutant was g-mhP
mutant (derived from I8L), supporting evidence that both macro-
cyclic ring conformation imparted by themhP ring constraint and
hydrogen bonding from the d-hydroxyl group are important in
achieving full activity in GE37468 variants.
The structure does not provide clear evidence for why the
conservative mutations F5Y and Y7F cause a marked decrease
in antibiotic activity. GTP binding has been shown to elicit a large
conformational change in EF-Tu, which allows domain 1 to
contact the southern half of the antibiotic in the region (Figure 6)
(Parmeggiani et al., 2006). These aromatic rings have been
shown to be in proximity on the southern half of the molecule
by NMR NOE experiments (Morris et al., 2009). It is possible
that the addition or removal of the phenolic oxygen from residue
5 or 7 alters the interaction between the antibiotic and domain 1
and leads to destabilization of this structure. In the Y7F mutant,
disruption of a transannular hydrogen bond between the
phenolic oxygen of Tyr7 and carbonyl 2, identified in the recently
solved thiomuracin-EF-Tu structure (Lamarche et al., 2012b),
may destabilize the antibiotic structure.
Mutations S13A and S13G lose 16- and 64-fold potency,
respectively, compared with wild-type dhA13. The C-terminal
dhA residues of GE37468 and thiomuracin are not conserved
in GE2270, and it is therefore difficult to rationalize what struc-
tures in this region of the molecule would be required for optimal
binding. However, a protein tunnel formed by a salt bridge
between residues R223 and E271 may require a well-defined
conformation around the bound antibiotic tail. This conformation
may be disrupted through the loss of the dhA13 sp2 center by
replacement with Ala or Gly. It is worthy to note that significant
semisynthetic SAR efforts by a group at Novartis have been
applied to the GE2270 C-terminal tail immediately following thia-
zole 12. This work has provided evidence for the importance of
chemical functionalities in this region of 29-membered thiopep-
tides for EF-Tu binding as well as increasing solubility (LaMarche
et al., 2012a; Leeds et al., 2011).
SIGNIFICANCE
The highly constrained macrocyclic architectures of thio-
peptides may be considered privileged structures for
bioactivity due to their reduced entropic costs of binding1608 Chemistry & Biology 19, 1600–1610, December 21, 2012 ª2012and proteolytic stability and, as such, are ideal molecules
for scaffolding peptide evolution. Although single amino
acid point mutations and gene deletions have been em-
ployed to manipulate thiopeptide structures in other
contexts, here, we use a technique to exhaustively explore
chemical space at individual residues through codon
randomization. Peptide diversification to explore chemical
space in natural product peptides is a complementary effort
to other in vivo peptide evolution methodologies such as
split intein methods or the use of unnatural amino acids in
natural product biosynthesis (Tianero et al., 2012; Young
et al., 2011) and holds the potential to create novelmolecules
with enhanced or modulated bioactivities. The work pre-
sented here goes beyond the existing methods to produce
molecules that provide a wealth of information not only on
SAR but also on the biosynthetic capacity of the thiopeptide
PTM pathway. Application of this methodology to the
construction of peptide libraries designed to target resistant
EF-Tu mutants may provide a method of counterevolving
thiopeptide antibiotics to evolving resistance. Furthermore,
this methodology may be readily adapted to the study of
other thiopeptide subclasses such as thiocillins and thio-
strepton, as well as to other PRPS natural products such
as the lantibiotics and cyanobactins.EXPERIMENTAL PROCEDURES
GE37468 Expression and Extraction
General methods for the growth, transformation, and storage of Streptomyces
adhered to guidelines found in Practical Streptomyces Genetics (Kieser et al.,
2000). Expression and extraction of GE37468 and analogs were performed as
previously described (Young and Walsh, 2011) and are detailed in the Supple-
mental Experimental Procedures.Subcloning Procedures
The getA gene was subcloned to pKC1218 (Kieser et al., 2000) with a specti-
nomycin-resistant marker and exogenous Erm promoter (Bibb et al., 1985) by
PCR amplification of the getA gene using primers ‘‘getA PstI RBS F’’ and
‘‘getA XbaI R’’ (Table S2). PCR product was digested with restriction enzymes
PstI and XbaI and ligated into the similarly digested pKC1218 vector to create
pKC1218-PErmE-getA. To subclone getA to pMS82 (Gregory et al., 2003),
getA with flanking DNA (Figure S2B) was PCR amplified with primers
‘‘GetA-pMS82 F’’ and ‘‘GetA-pMS82 R,’’ digested with HindIII and KpnI,
and ligated to the similarly digested pMS82 plasmid. To facilitate cloning of
mutants, an XhoI site was added immediately following the structural gene
using PCR-directed mutagenesis (Zheng et al., 2004) with primers ‘‘A XhoI
F’’ and ‘‘A XhoI R’’ to create pMS82-getA. PCR mutagenesis was used to
create the thiomuracin-coding sequence (T2C) using primers ‘‘A T2C F’’
and ‘‘A T2C R’’ and the GE2270-coding sequence (T2C, F5V, Y7G, I8F) using
primers ‘‘A GE2270 F’’ and ‘‘A GE2270 R.’’ Libraries were created using the
‘‘GetA F new primer’’ forward primer and the ‘‘MS82 NNK2 R,’’ ‘‘MS82
NNK3 R,’’ ‘‘MS82 NNK4 R,’’ ‘‘MS82 NNK5 R,’’ ‘‘MS82 NNK7 R,’’ ‘‘MS82
NNK8 R,’’ or ‘‘MS82 NNK13 R’’ reverse primers to randomize residues 2, 3,
4, 5, 7, 8, and 13, respectively. PCR products were digested with ScaI and
XhoI and ligated into the similarly digested pMS82-getA plasmid. To achieve
consistent expression from colonies on agar plates, it was necessary to trans-
fer libraries from pMS82 into the pSETGE1 plasmid. This was accomplished
by incorporating an SpeI site immediately following the getA gene in
pSETGE1 by PCR-directed mutagenesis with primers ‘‘SpeI F’’ and
‘‘SpeI R.’’ Libraries were then transferred to an ScaI and SpeI-digested
pSETGE1 plasmid by PCR from pMS82-getA with primers ‘‘GetA Gib F’’
and ‘‘GetA Gib R’’ and ligation using the Gibson/Venter method of isothermal
assembly (Gibson et al., 2008).Elsevier Ltd All rights reserved
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Colonies produced using methods described in the Supplemental Experi-
mental Procedures were mixed with MALDI-TOF Matrix (40 mg of Sigma-Al-
drich, 50% 2,5-dihydroxybenzoic acid, 50% 2-cyano-3-(4-hydroxyphenyl)
acrylic acid in 1 ml of 78% acetonitrile, 21.9% water, 0.1% trifluoracetic
acid) and spotted on a 384-well Bruker stainless steel target plate. Spectra
were acquired on an autoflex speed MALDI-TOF mass spectrometer (Bruker
Daltonics) using parameters outlined in the Supplemental Experimental Proce-
dures and analyzed using flexAnalysis 3.3 (Bruker Daltonics). Heatmaps were
created using ClinProTools 2.2 (Bruker Daltonics).
Antibacterial Overlay and Quantification
Spore stocks of libraries in M1152 were spread on BTT agar at a density of 2
colonies/cm2. After incubation for 6 days at 30C, plates were overlaid
with 15 ml of B. subtilis in soft agar (1:10,000 dilution of a saturated overnight
B. subtilis culture in LB broth containing 0.7% agar at 35C–40C). Overlaid
plates were incubated for an additional 16 hr at 30C. Colonies that produced
clear zones of inhibition as illustrated in Figure 5 were picked from beneath the
overlaid soft agar and restruck on SFM plates containing apramycin (50 mg/ml)
and nalidixic acid (25 mg/ml) to select for growth of the Streptomyces M1152
library variant. Colony sequencing was performed as above. Quantification
of antibacterial activity (MIC assays) against B. subtilis PY79, MRSA COL,
and MRSA MW2 was performed using the overnight culture/serial dilution
assay as previously reported (Acker et al., 2009; Bowers et al., 2010a, 2012;
Young and Walsh, 2011). Additional details on MIC assays and sample purifi-
cation are described in Figure S5.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.chembiol.2012.10.013.
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